Note: GLP-1 medications can cause nausea, vomiting, delayed stomach emptying, andin rare casesserious complications, and should be used only with proper medical supervision This information is not FDA-reviewed, and the product is not intended for diagnosis, treatment, cure, or prevention of disease
(2024) Adipex-P highlights of prescribing information, Teva Pharmaceuticals USA (2012) Pharmacotherapy of obesity: an update on the available medications and drugs under investigation, eClinicalMedicine (2023) GLP-1 receptor agonists and the risk of thyroid cancer, Diabetes Care (2023) Once-weekly semaglutide in adults with overweight or obesity, The New England Journal of Medicine (2021) Medications for obesity management: Effectiveness and value, Journal of Managed Care & Specialty Pharmacy (2023) Comparison of continuous and intermittent anorectic therapy in obesity, The BMJ (1968) Topiramate and phentermine, StatPearls (2023) Orlistat (marketed as Alli and Xenical) information, U.S
Identity Verification Purity Analysis Independent Testing We do not expect our customers to accept the purity claims on good faith
Semaglutide was notably associated with high risks of ischemic optic neuropathy and diabetic retinopathy